BrightSpring Health Services, Inc. Common Stock (BTSG) Revenue History
Annual and quarterly revenue from 2019 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
BTSG Revenue Growth
Revenue Breakdown (FY 2025)
BTSG's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
BTSG Revenue Analysis (2019–2025)
As of May 6, 2026, BrightSpring Health Services, Inc. Common Stock (BTSG) generated trailing twelve-month (TTM) revenue of $13.65 billion, reflecting exceptional growth of +25.6% year-over-year. The most recent quarter (Q1 2026) recorded $3.61 billion in revenue, up 1.8% sequentially.
Looking at the longer-term picture, BTSG's 5-year compound annual growth rate (CAGR) stands at +18.3%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $12.91 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows BTSG's business is primarily driven by Commercial Insurance (69%), and Medicaid (31%). With over half of revenue concentrated in Commercial Insurance, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including LFST (+13.9% YoY), ACHC (+6.8% YoY), and ENSG (+19.2% YoY), BTSG has outperformed the peer group in terms of revenue growth. Compare BTSG vs LFST →
BTSG Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| BTSGCurrent | $13.6B | +25.6% | +18.3% | 3.2% | |
 LFST | $1.4B | +13.9% | +30.4% | 1.8% | |
 ACHC | $3.3B | +6.8% | +9.7% | 11.7% | |
 ENSG | $5.1B | +19.2% | +16.1% | 8.6% | |
 ADUS | $1.4B | +19.6% | +13.2% | 9.7% | |
 CCRN | $1.1B | -21.6% | +4.7% | -0.3% |
BTSG Historical Revenue Data (2019–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $12.91B | +14.6% | $1.52B | 11.8% | $408.1M | 3.2% |
| 2024 | $11.27B | +27.6% | $1.59B | 14.1% | $206.4M | 1.8% |
| 2023 | $8.83B | +14.3% | $1.43B | 16.2% | $147.2M | 1.7% |
| 2022 | $7.72B | +15.3% | $1.35B | 17.5% | $187.8M | 2.4% |
| 2021 | $6.70B | +20.0% | $1.25B | 18.6% | $234.2M | 3.5% |
| 2020 | $5.58B | +23.3% | $1.05B | 18.8% | $165.2M | 3.0% |
| 2019 | $4.53B | - | $833.9M | 18.4% | $63.3M | 1.4% |
Full BTSG Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See BTSG's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BTSG Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BTSG vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBTSG — Frequently Asked Questions
Quick answers to the most common questions about buying BTSG stock.
Is BTSG's revenue growth accelerating or slowing?
BTSG revenue is accelerating at +25.6% year-over-year, exceeding the 5-year CAGR of +18.3%. TTM revenue reached $13.6B. Growth momentum has increased versus prior periods.
What is BTSG's long-term revenue growth rate?
BrightSpring Health Services, Inc. Common Stock's 5-year revenue CAGR of +18.3% reflects the sustained expansion pattern. Current YoY growth of +25.6% is above this long-term average.
How is BTSG's revenue distributed by segment?
BTSG reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2025 are available for download. Segment mix reveals concentration and diversification trends.